---
schema_version: "secwatch.filing_event.v1"
accession: "0001376339-26-000012"
form_type: "8-K"
ticker: "MDXG"
cik: "0001376339"
company_name: "MIMEDX GROUP, INC."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:11:06.250559+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# MiMedx posts record Q4 sales $118M (+27% YoY); 2026 guidance $340-360M; $100M buyback

## Summary
- Q4 net sales $118M, +27% YoY; full-year $419M, +20% YoY.
- Q4 GAAP net income $15M ($0.10 EPS); Adjusted EBITDA $29M (25% margin).
- 2026 net sales guidance $340-360M, down from 2025 actual; Adj EBITDA margin mid-to-high teens.
- Board authorizes $100M share repurchase program over two years.
- Cash & equivalents $166M; net cash $148M; SG&A up 18% to $266M on higher commissions.

## SEC filing metadata
- accession: 0001376339-26-000012
- form_type: 8-K
- ticker: MDXG
- cik: 0001376339
- company_name: MIMEDX GROUP, INC.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1376339/000137633926000012/0001376339-26-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1376339/000137633926000012/mdxg-20260225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001376339-26-000012
- JSON: https://secwatch.observer/filing/0001376339-26-000012.json
- Plain text: https://secwatch.observer/filing/0001376339-26-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.